NEW YORK (GenomeWeb News) - Harvard Bioscience yesterday said first-quarter revenue rose 10 percent as R&D spending increased 12 percent, and net income slipped 8 percent.
 
Total receipts for the three months ended March 31, 2007, increased to $19.1 million from $17.4 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.